Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021)
Cumberland Pharmaceuticals (CPIX) posted Cash from Discontinued Operations of 503318.0 for Q4 2021, up 1.31% sequentially from 496787.0 in Q3 2021, and down 62.78% YoY from 1352156.0 in Q4 2020.
Cumberland Pharmaceuticals (CPIX) Cash from Discontinued Operations (2019 - 2021) Analysis & Trends
Cumberland Pharmaceuticals has reported Cash from Discontinued Operations for 3 years, with the latest figure at 503318.0 in Q4 2021.
- Quarterly Cash from Discontinued Operations fell 62.78% year-over-year to 503318.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was 503318.0 (down 82.3% YoY) and the FY2021 annual result came in at 1994322.0, down 43.31% from the prior year.
- Cash from Discontinued Operations rose to 503318.0 in Q4 2021 per CPIX's latest filing, from 496787.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 3027800.0 in Q4 2019 and troughed at 38567.0 in Q2 2020.
- A 3-year average of 918680.0 and a median of 648983.5 in 2020 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2020 and 2021: Cash from Discontinued Operations tumbled 97.11% in 2020, then jumped 1193.35% in 2021.
- Over 3 years, Cash from Discontinued Operations stood at 3027800.0 in 2019, then sank by 55.34% to 1352156.0 in 2020, then sank by 62.78% to 503318.0 in 2021.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 503318.0, 496787.0, and 498807.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 503,318.00 |
| Dec 31, 2021 | 503,318.00 |
| Sep 30, 2021 | 496,787.00 |
| Sep 30, 2021 | 496,787.00 |
| Jun 30, 2021 | 498,807.00 |
| Jun 30, 2021 | 498,807.00 |
| Mar 31, 2021 | 495,410.00 |
| Mar 31, 2021 | 495,410.00 |
| Dec 31, 2020 | 1.35 Mn |
| Dec 31, 2020 | 1.35 Mn |
| Sep 30, 2020 | 794,649.00 |
| Sep 30, 2020 | 794,649.00 |
| Jun 30, 2020 | 38,567.00 |
| Jun 30, 2020 | 38,567.00 |
| Mar 31, 2020 | 1.33 Mn |
| Mar 31, 2020 | 1.33 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Sep 30, 2019 | 918,192.00 |
| Sep 30, 2019 | 918,192.00 |